Please do not leave this page until complete. This can take a few moments.
Marlborough-based drug manufacturer TheracosBio has named Brian Connelly as its new president and CEO.
Connelly joins the company after it emerged from clinical trial phases in January to commercialize its drug, Brenzavvy, a type 2 diabetes treatment approved by the U.S. Food and Drug Administration. TheracosBio named its first CFO in March.
Connelly has two decades of experience in law and business in the biopharmaceutical industry, according to a Tuesday press release from the company. He is the co-founder of IncreVet, a Boston veterinary drug development firm that received FDA approval for a feline diabetes treatment. The firm was acquired by the parent company of TheracosBio, Theracos, Inc., in 2022.
TheracosBios’s previous CEO, Albert Collinson, is stepping down after being with the company from phase 1 clinical trials to commercial launch, according to the press release. He will remain an advisor to the company.
Connelly earned his bachelor’s degree from Boston College and his law degree from the George Washington University Law School in Washington, D.C.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments